AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 31st, 2009 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2009 Company IndustryThis FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (“Amendment”), dated as of December 29, 2008, is between La Jolla Pharmaceutical Company, a Delaware corporation, with its principal place of business located at 6455 Nancy Ridge Drive, San Diego, California 92121 (the “Employer”), and Jessie Elchico (the “Employee”).
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 31st, 2009 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2009 Company IndustryThis FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (“Amendment”), dated as of December 30, 2008, is between La Jolla Pharmaceutical Company, a Delaware corporation, with its principal place of business located at 6455 Nancy Ridge Drive, San Diego, California 92121 (the “Employer”), and Michael Tansey (the “Employee”).
AMENDMENT TO CHIEF EXECUTIVE OFFICER EMPLOYMENT AGREEMENTChief Executive Officer Employment Agreement • March 31st, 2009 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2009 Company IndustryThis SECOND AMENDMENT TO CHIEF EXECUTIVE OFFICER EMPLOYMENT AGREEMENT (“Amendment”), dated as of December 31, 2008, is between La Jolla Pharmaceutical Company, a Delaware corporation, with its principal place of business located at 6455 Nancy Ridge Drive, San Diego, California 92121 (the “Employer”), and Deirdre Y. Gillespie (the “Employee”).
December 26, 2008 Luke Seikkula [Address] Re: First Amendment to Offer of Employment Dear Luke:First Amendment to Offer of Employment • March 31st, 2009 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2009 Company IndustryThis letter amends the terms of the Offer of Employment (the “Agreement”) dated as of March 4, 2008, by and between La Jolla Pharmaceutical Company (“LJPC”) and you as set forth below. Capitalized terms not defined herein shall have the meaning specified in the Agreement.
December 26, 2008 Vickie Motte [Address] Re: First Amendment to Offer of Employment Dear Vickie:First Amendment to Offer of Employment • March 31st, 2009 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2009 Company IndustryThis letter amends the terms of the Offer of Employment (the “Agreement”) dated as of September 19, 2008, by and between La Jolla Pharmaceutical Company (“LJPC”) and you as set forth below. Capitalized terms not defined herein shall have the meaning specified in the Agreement.
December 29, 2008 Lisa Koch-Hulle [Address] Re: First Amendment to Offer of Employment Dear Lisa:First Amendment to Offer of Employment • March 31st, 2009 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2009 Company IndustryThis letter amends the terms of the Offer of Employment (the “Agreement”) dated as of March 4, 2008, by and between La Jolla Pharmaceutical Company (“LJPC”) and you as set forth below. Capitalized terms not defined herein shall have the meaning specified in the Agreement.
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 31st, 2009 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2009 Company IndustryThis FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (“Amendment”), dated as of December 24, 2008, is between La Jolla Pharmaceutical Company, a Delaware corporation, with its principal place of business located at 6455 Nancy Ridge Drive, San Diego, California 92121 (the “Employer”), and Gail Sloan (the “Employee”).
AMENDMENT TO EXECUTIVE OFFICER EMPLOYMENT AGREEMENTExecutive Officer Employment Agreement • March 31st, 2009 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2009 Company IndustryThis FIRST AMENDMENT TO CHIEF FINANCIAL OFFICER, CHIEF BUSINESS OFFICER AND EXECUTIVE VICE-PRESIDENT EMPLOYMENT AGREEMENT (“Amendment”), dated as of December 24, 2008, is between La Jolla Pharmaceutical Company, a Delaware corporation, with its principal place of business located at 6455 Nancy Ridge Drive, San Diego, California 92121 (the “Employer”), and Niv Caviar (the “Employee”).